Revive Biotechnology
Champaign
About Revive Biotechnology
Revive Biotechnology improves oxygen delivery to hypoxic tissues by utilizing innovative nanotechnology. Research and development is currently focused on treatment for central retinal artery occlusion with potential future applications for additional ocular ischemic conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $256.0K
- Last round: Grant (Nov 2020)
- Website: revivebiotech.com
Industries & Categories
Biotechnology, Health Care, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/revive-biotechnology-107198 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.